Artificial IntelligenceAISurvey6 A+NCT07326501
Attitudes and Perceptions of Corresponding Authors From Top International Medical Journals Regarding the Use of Artificial Intelligence in the Scientific Process
An observational study of Artificial Intelligence and Biomedical Research, run by Centre Hospitalier Universitaire de Nice at 1 site in France.
Trial summary
"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research. These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts… Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Artificial Intelligence, Biomedical Research, Scientific Publishing
- What is being tested?
- observational survey
- How many people
- 500 participants
- Where
- 1 siteFrance
- Study dates
- 10 Dec 2025to 30 Jun 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The study population consists of corresponding authors who have published scientific articles in leading international medical journals. Participants are identified through publicly available publication data from six major journals (The New England Journal of Medicine, The Lancet, JAMA, Nature, Science, and The BMJ) and are invited to participate via professional email addresses. The population includes adult researchers from diverse biomedical and medical disciplines, with no geographic restriction.
Who may be able to join
- Participants without any disease, condition, or related symptoms are permitted to participate. This study is a non-clinical, observational survey focusing on attitudes and practices related to artificial intelligence in scientific research, not on health conditions.
Who cannot join
- Authors who are not corresponding authors.
- Students, residents, interns, or trainees without corresponding author status.
- Individuals not involved in biomedical or medical research activities.
- Individuals who decline to participate or do not complete the online questionnaire.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research. These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts, and preparing articles for publication. While interest in AI is growing rapidly, there is still limited information on how these tools are actually perceived and used by leading medical researchers. This study aims to better understand the attitudes, perceptions, and self-reported uses of artificial intelligence among corresponding authors who have published in six major international medical journals. These authors play a key role in shaping scientific standards and editorial practices, and their views are essential to understanding how AI may influence the future of medical research. Participants are invited to complete an anonymous online questionnaire that asks about their familiarity with AI tools, how and when they use or plan to use them in the research process, the potential benefits they perceive, and the concerns or limitations they identify. The survey also explores participants' expectations regarding transparency, ethical guidance, and journal policies related to the use of artificial intelligence in scientific work.The study is observational and does not involve any medical intervention or collection of personal or health-related data. Participation is voluntary, and responses are fully anonymous.
- Conditions
- Artificial Intelligence, Biomedical Research, Scientific Publishing, Surveys and Questionnaires
- Being tested
- observational survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
observational surveyOther
This is an observational, non-interventional study based on an anonymous online questionnaire. No intervention is administered to participants.
| Study group | Role | What they receive |
|---|---|---|
| Authors Survey Group | This label identifies the single cohort of participants, consisting of corresponding authors invited to complete the anonymous online survey. No comparison or control groups are included. Receives: Other: observational survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-reported attitudes regarding the use of artificial intelligence in the scientific research process
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
Measured: At the inclusion
Perceptions regarding the use of artificial intelligence in the scientific research process
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
Measured: At the inclusion
Secondary outcomes (4)
Self-reported patterns of use, regarding artificial intelligence tools in scientific research and publishing
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
Measured: At the inclusion
Perceived benefits regarding artificial intelligence tools in scientific research and publishing
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
Measured: At the inclusion
Risk regarding artificial intelligence tools in scientific research and publishing
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
Measured: At the inclusion
Expectations regarding artificial intelligence tools in scientific research and publishing
Anonymous online questionnaire developed for this study Responses are collected using multiple-choice questions and Likert-scale items. Higher scores reflect greater reported use of artificial intelligence and more positive evaluations of its benefits, while higher concern scores reflect greater perceived risks or limitations
Measured: At the inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2026
- Study start10 Dec 2025
- Primary completion10 Mar 2026 (estimated)
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Artificial IntelligenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07326501
- Sponsor's protocol ID
- 25Chirplast02
- Acronym
- AISurvey6 A+
- Status last verified
- Dec 2025
- First submitted
- 24 Dec 2025
- Last updated
- 8 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Attitudes and Perceptions of Corresponding Authors From Top International Medical Journals Regarding the Use of Artificial Intelligence in the Scientific Process
- ClinicalTrials.gov ID
- NCT07326501
- Acronym / sponsor ID
- AISurvey6 A+ / 25Chirplast02
- Conditions
- Artificial Intelligence, Biomedical Research, Scientific Publishing, Surveys and Questionnaires
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire de NiceUniversity, hospital or other
- Study start
- 10 Dec 2025 (actual)
- Primary completion
- 10 Mar 2026 (estimated)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 8 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research. These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts, and preparing articles for publication. While interest in AI is growing rapidly, there is still limited information on how these tools are actually perceived and used by leading medical researchers. This study aims to better understand the attitudes, perceptions, and self-reported uses of artificial intelligence among corresponding authors who have published in six major international medical journals. These authors play a key role in shaping scientific standards and editorial practices, and their views are essential to understanding how AI may influence the future of medical research. Participants are invited to complete an anonymous online questionnaire that asks about their familiarity with AI tools, how and when they use or plan to use them in the research process, the potential benefits they perceive, and the concerns or limitations they identify. The survey also explores participants' expectations regarding transparency, ethical guidance, and journal policies related to the use of artificial intelligence in scientific work.The study is observational and does not involve any medical intervention or collection of personal or health-related data. Participation is voluntary, and responses are fully anonymous.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Authors Survey Group | – | Other: observational surveyThis label identifies the single cohort of participants, consisting of corresponding authors invited to complete the anonymous online survey. No comparison or control groups are included. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The study population consists of corresponding authors who have published scientific articles in leading international medical journals. Participants are identified through publicly available publication data from six major journals (The New England Journal of Medicine, The Lancet, JAMA, Nature, Science, and The BMJ) and are invited to participate via professional email addresses. The population includes adult researchers from diverse biomedical and medical disciplines, with no geographic restriction.
Key inclusion criteria (1 listed)
- Participants without any disease, condition, or related symptoms are permitted to participate. This study is a non-clinical, observational survey focusing on attitudes and practices related to artificial intelligence in scientific research, not on health conditions.
Key exclusion criteria (4 listed)
- Authors who are not corresponding authors.
- Students, residents, interns, or trainees without corresponding author status.
- Individuals not involved in biomedical or medical research activities.
- Individuals who decline to participate or do not complete the online questionnaire.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| observational surveyThis is an observational, non-interventional study based on an anonymous online questionnaire. No intervention is administered to participants. | Other | Authors Survey Group |
Primary outcome
Self-reported attitudes regarding the use of artificial intelligence in the scientific research process
Time frame: At the inclusion
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
Perceptions regarding the use of artificial intelligence in the scientific research process
Time frame: At the inclusion
Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.
4 secondary outcomes
Self-reported patterns of use, regarding artificial intelligence tools in scientific research and publishing
Time frame: At the inclusion
Perceived benefits regarding artificial intelligence tools in scientific research and publishing
Time frame: At the inclusion
Risk regarding artificial intelligence tools in scientific research and publishing
Time frame: At the inclusion
Expectations regarding artificial intelligence tools in scientific research and publishing
Time frame: At the inclusion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2026.
Related trials for Artificial Intelligence
Not yet recruiting
MAGICS - Multi-Agent Generative AI in Clinical Simulation for Clinical Deterioration Training
Clinical Reasoning in Nursing Education, Virtual Simulation
Enrolling by invitationObservational study
What Should we Measure? A Qualitative Interview Study on Outcomes for Evaluating AI-assisted Medical Image Interpretation.
Artificial Intelligence Perception and Attitude
Enrolling by invitationObservational study
Safety, Feasibility, and Acceptability of the MINERVA Voice Conversational Agent for Emergency Department History-Taking
History Taking, Artificial Intelligence (AI)
Not yet recruiting
The Impact of AI-Assisted Diagnosis and Treatment on Physicians' Potential Legal Liability: An Expert Perspective
Medical Malpractice, Artificial Intelligence in Medicine
Enrolling by invitationObservational study
Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids
Uterine Fibroid, Uterine Sarcoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Artificial Intelligence and Biomedical Research, run by Centre Hospitalier Universitaire de Nice at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 8 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-reported attitudes regarding the use of artificial intelligence in the scientific research process (time frame: At the inclusion). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2026; AzTrials last refreshed its copy on 26 Oct 2026.